Atlas Trials

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

Clinical trial NCT00709215 · UNKNOWN

Trial details

NCT number
NCT00709215
Sponsor
OncoVista, Inc.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Refractory TdT-Positive Leukemia
Start date
2008-06-01
Primary completion
2010-12-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.